Med Tech Company Hit With Shareholder Suit Over Alleged Misstatements
TAMPA, Fla. — A medical technology company and its CEO misrepresented the clinical study results for its plasma-based surgical product in violation of federal securities laws, a shareholder argues in an...To view the full article, register now.
Already a subscriber? Click here to view full article